To the best of our knowledge, this is the first study to show reduced levels of ACE2 in the oropharyngeal cells of CF patients compared with healthy individuals; furin and TMPRSS2 also showed a trend toward reduction in CF patients. This evidence concerns the gene TMPRSS2 and cystic fibrosis.